GSK press releases Follow GSK’s licensor Hansoh Pharma announces positive phase III results for Ris-Rez in China patient population ARTEMIS-008 met its primary endpoint of overall survival in advanced or relapsed small-cell lung cancer https://www.gsk.com/en-gb/media/press-releases/gsk-s-licensor-hansoh-pharma-announces-positive-phase-iii-results-for-ris-rez-in-china-patient-population/ gsk.com
